'And sickle-cell disease, in addition, affects certain communities. We need to get the message to these groups,' she added.
Ruder Finn is aiming to boost awareness of genetic-screening programmes, so those affected can be treated with Exjade, a daily oral treatment.
Avenue HKM is working on UK med ed work for the Exjade campaign (PRWeek, 21 October).
The drug is currently awaiting a licence in the UK and US.